We are live on ! Find out more
MDT icon

Medtronic

1,992 hedge funds and large institutions have $88B invested in Medtronic in 2023 Q1 according to their latest regulatory filings, with 187 funds opening new positions, 990 increasing their positions, 622 reducing their positions, and 119 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 990 | Existing positions reduced: 622

57% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 119

32% more capital inflows, than outflows

Capital inflows: $5.19B | Capital outflows: $3.93B

20% more call options, than puts

Call options by funds: $666M | Put options by funds: $555M

1% more funds holding

Funds holding: 1,963 → 1,992 (+29)

1.04% more ownership

Funds ownership: 80.97% → 82.01% (+1%)

13% less funds holding in top 10

Funds holding in top 10: 31 → 27 (-4)

Holders
1,992
Holders Change
+29
Holders Change %
+1.48%
% of All Funds
31.66%
Holding in Top 10
27
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-12.9%
% of All Funds
0.43%
New
187
Increased
990
Reduced
622
Closed
119
Calls
$666​M
Puts
$555​M
Net Calls
+$112​M
Net Calls Change
-⁠$265​M

MDT Hedge Fund Activity: Q1 2023 in Review

1,992 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2023, worth a combined $88B — up 5.1% from $83.7B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MDT positions and 119 closed out — a net gain of 68 holders — while 990 added to existing stakes and 622 trimmed.

The largest buyer was Ameriprise, adding an estimated $281M. The largest seller was BlackRock, cutting an estimated $375M.

  • 1,992 institutional investors held Medtronic (MDT) as of Q1 2023, up from 1,963 in Q4 2022.
  • Funds reported $88B of Medtronic stock for Q1 2023, up 5.1% quarter-over-quarter.
  • 187 funds opened new Medtronic positions in Q1 2023 and 119 closed out, a net change of +68 holders.
  • The largest Medtronic buyer in Q1 2023 was Ameriprise, an estimated $281M added.
  • The largest Medtronic seller in Q1 2023 was BlackRock, an estimated $375M sold.

Based on aggregated 13F filings for Q1 2023.